Surgery Outcome Articles & Analysis
86 news found
The focus will be on how easy the software is to use, how well it fits into existing surgical routines, and how it impacts the outcomes of the surgeries performed. The AI in Modus Plan helps automate the process of mapping the brain, making it easier for surgeons to navigate during operations. ...
Listen to Synaptive’s President and Co-Founder, Cameron Piron on the Epicor weekly episode of Manufacturing the Future with Kerrie Jordan. Cameron shares invaluable leadership and entrepreneurial insights, reflecting on the journey of founding and growing Synaptive globally, how he leverages artificial intelligence to enhance surgical outcomes and streamline medical procedures, and the ...
A new cohort study published in World Neurosurgery by the Neurosurgery Department at Medical University of South Carolina (MUSC) examined the use of the Synaptive Modus exoscope (n=123) versus a microscope (n=123) in spine surgery. The use of the exoscope resulted in shorter operative time, reduced blood loss, shorter length of stay and favorable clinical ...
Caresyntax, the leading vendor of enterprise-scale data-driven surgical intelligence solutions to make surgery safer and smarter, today announced its highlights and achievements of 2023, as the company has continued its strong growth journey. ...
“The ability to capture and deliver data insights across the entire cycle of care presents a new avenue for partners to measure value and improve outcomes with a data-first approach. By adding proven methodologies like Dr. ...
Together, we will expand and enhance the decision-making precision of both platforms, providing actionable insights to surgeons, care teams and administrators throughout the surgical continuum, to make surgery safer and more effective.” Arya H. Bolurfrushan, Founder and CEO, AAICO: “We are looking forward to working closely with Caresyntax. ...
We particularly focused on devices that reduce surgery time and improving patient outcomes,” said Dr Jeffery. ...
” About The American College of Cardiology The American College of Cardiology envisions a world where innovation and knowledge optimize cardiovascular care and outcomes. As the professional home for the entire cardiovascular care team, the mission of the College and its more than 56,000 members is to transform cardiovascular care and to improve heart health. ...
October marks a month dedicated to a cause close to the core of everything which we do at Cirdan: Breast Cancer Awareness. This month will see a surge in activism surrounding breast cancer awareness and a push for finding a cure from around the globe. The fight to treat and cure breast cancer continues constantly, and we pride ourselves in taking part in the fight to save lives. Breast cancer ...
Key potential benefits cited in the BDD application include less invasive and shorter surgery, improved intra- and post-operative outcomes, reduction or elimination of hospitalization length of stay, and improved patient quality of life, including motion-preservation at the affected spinal level. "Our receipt of the Breakthrough Device Designation is a welcome ...
Jeremy Richmon, MD is leading a new clinical trial sponsored by Alume, the Center for Clinical Research Operations' (CCRO) first clinical trial with Head and Neck Surgery. The trial involves using a tracer to help identify nerves intraoperatively. This type of cutting edge translational surgical innovation improves outcomes and ultimately the lives of our ...
Today we are announcing the successful completion of urological surgeries with Dexter® – the first and only on-demand robotic surgery platform. ...
June 8.2022 - Medical Microinstruments (MMI), a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, today announced that it will participate in "THE MINIMALLY INVASIVE ROBOTIC SURGERY SYSTEMS project (TREMIRS). ...
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced the publication of the 2022 Annual Letter to Shareholders published in the Company's Proxy Statement for its Annual Meeting of Stockholders ...
“Our team continues to be impressed by the strides Proprio has made in computer vision and data intelligence for enhancing surgical outcomes. I look forward to being involved in this exciting phase of the company’s ...
Steven Schwaitzberg, SUNY Distinguished Service Professor and Chairman of Surgery in the Jacobs School at UB. “I was impressed by the ActivSight imaging module’s capabilities, specifically its ability to enhance visualization capabilities during surgical procedures. ...
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announces that the U.S. Food and Drug Administration (the "FDA") has completed its review of the Company's appeal for 510(k) clearance for its Evo® sEEG Electrode ...
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announces its operating results for the second quarter of fiscal year 2022 ended March 31, 2022. Second Quarter and Recent Business Updates Evo® sEEG electrode ...
As such, we are excited to inform you that Pelican Feminine Healthcare Ltd trading as Single Use Surgical has now been consolidated and rebranded to Eakin Surgical Ltd. Eakin Surgical is part of Eakin Healthcare Group, established since 1974 with an extensive heritage and experience in the manufacturing and supply of medical products to the healthcare industry. Rest assured that our product ...
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders today announced that, effective April 4, 2022, the Compensation Committee of the Board of Directors approved an equity award under the NeuroOne Medical Technologies ...